The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Preclinical CRO Services-Global Market Insights and Sales Trends 2024
Synopsis
The global Preclinical CRO Services market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Preclinical CRO Services in various end use industries. The expanding demands from the Pharmaceutical Industry, Biotechnology and Other,, are propelling Preclinical CRO Services market. Oncology, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Cardiology segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Preclinical CRO Services market, driven by demand from China, the second largest economy with some signs of stabilising, the Preclinical CRO Services market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Preclinical CRO Services, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Preclinical CRO Services market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Preclinical CRO Services market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Preclinical CRO Services sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Preclinical CRO Services covered in this report include Labcorp, Charles River, ICON, PPD, Eurofins Scientific, Taconic Biosciences, EVOTEC, The Jackson Laboratory and MI Bioresearch, etc.
The global Preclinical CRO Services market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Labcorp
Charles River
ICON
PPD
Eurofins Scientific
Taconic Biosciences
EVOTEC
The Jackson Laboratory
MI Bioresearch
Champion Oncology
Wuxi AppTec.
Xentech
Living Tumor Laboratory
CrownBio
Global Preclinical CRO Services market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Preclinical CRO Services market, Segment by Type:
Oncology
Cardiology
Infectious Disease
Metabolic Disorders
Others
Global Preclinical CRO Services market, by Application
Pharmaceutical Industry
Biotechnology
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Preclinical CRO Services companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Preclinical CRO Services market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Preclinical CRO Services in various end use industries. The expanding demands from the Pharmaceutical Industry, Biotechnology and Other,, are propelling Preclinical CRO Services market. Oncology, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Cardiology segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Preclinical CRO Services market, driven by demand from China, the second largest economy with some signs of stabilising, the Preclinical CRO Services market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Preclinical CRO Services, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Preclinical CRO Services market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Preclinical CRO Services market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Preclinical CRO Services sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Preclinical CRO Services covered in this report include Labcorp, Charles River, ICON, PPD, Eurofins Scientific, Taconic Biosciences, EVOTEC, The Jackson Laboratory and MI Bioresearch, etc.
The global Preclinical CRO Services market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Labcorp
Charles River
ICON
PPD
Eurofins Scientific
Taconic Biosciences
EVOTEC
The Jackson Laboratory
MI Bioresearch
Champion Oncology
Wuxi AppTec.
Xentech
Living Tumor Laboratory
CrownBio
Global Preclinical CRO Services market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Preclinical CRO Services market, Segment by Type:
Oncology
Cardiology
Infectious Disease
Metabolic Disorders
Others
Global Preclinical CRO Services market, by Application
Pharmaceutical Industry
Biotechnology
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Preclinical CRO Services companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Preclinical CRO Services
1.1 Preclinical CRO Services Market Overview
1.1.1 Preclinical CRO Services Product Scope
1.1.2 Preclinical CRO Services Market Status and Outlook
1.2 Global Preclinical CRO Services Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Preclinical CRO Services Market Size by Region (2018-2029)
1.4 Global Preclinical CRO Services Historic Market Size by Region (2018-2023)
1.5 Global Preclinical CRO Services Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Preclinical CRO Services Market Size (2018-2029)
1.6.1 North America Preclinical CRO Services Market Size (2018-2029)
1.6.2 Europe Preclinical CRO Services Market Size (2018-2029)
1.6.3 Asia-Pacific Preclinical CRO Services Market Size (2018-2029)
1.6.4 Latin America Preclinical CRO Services Market Size (2018-2029)
1.6.5 Middle East & Africa Preclinical CRO Services Market Size (2018-2029)
2 Preclinical CRO Services Market by Type
2.1 Introduction
2.1.1 Oncology
2.1.2 Cardiology
2.1.3 Infectious Disease
2.1.4 Metabolic Disorders
2.1.5 Others
2.2 Global Preclinical CRO Services Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Preclinical CRO Services Historic Market Size by Type (2018-2023)
2.2.2 Global Preclinical CRO Services Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Preclinical CRO Services Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Preclinical CRO Services Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Preclinical CRO Services Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Preclinical CRO Services Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Preclinical CRO Services Revenue Breakdown by Type (2018-2029)
3 Preclinical CRO Services Market Overview by Application
3.1 Introduction
3.1.1 Pharmaceutical Industry
3.1.2 Biotechnology
3.1.3 Other
3.2 Global Preclinical CRO Services Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Preclinical CRO Services Historic Market Size by Application (2018-2023)
3.2.2 Global Preclinical CRO Services Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Preclinical CRO Services Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Preclinical CRO Services Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Preclinical CRO Services Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Preclinical CRO Services Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Preclinical CRO Services Revenue Breakdown by Application (2018-2029)
4 Preclinical CRO Services Competition Analysis by Players
4.1 Global Preclinical CRO Services Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Preclinical CRO Services as of 2022)
4.3 Date of Key Players Enter into Preclinical CRO Services Market
4.4 Global Top Players Preclinical CRO Services Headquarters and Area Served
4.5 Key Players Preclinical CRO Services Product Solution and Service
4.6 Competitive Status
4.6.1 Preclinical CRO Services Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Labcorp
5.1.1 Labcorp Profile
5.1.2 Labcorp Main Business
5.1.3 Labcorp Preclinical CRO Services Products, Services and Solutions
5.1.4 Labcorp Preclinical CRO Services Revenue (US$ Million) & (2018-2023)
5.1.5 Labcorp Recent Developments
5.2 Charles River
5.2.1 Charles River Profile
5.2.2 Charles River Main Business
5.2.3 Charles River Preclinical CRO Services Products, Services and Solutions
5.2.4 Charles River Preclinical CRO Services Revenue (US$ Million) & (2018-2023)
5.2.5 Charles River Recent Developments
5.3 ICON
5.3.1 ICON Profile
5.3.2 ICON Main Business
5.3.3 ICON Preclinical CRO Services Products, Services and Solutions
5.3.4 ICON Preclinical CRO Services Revenue (US$ Million) & (2018-2023)
5.3.5 PPD Recent Developments
5.4 PPD
5.4.1 PPD Profile
5.4.2 PPD Main Business
5.4.3 PPD Preclinical CRO Services Products, Services and Solutions
5.4.4 PPD Preclinical CRO Services Revenue (US$ Million) & (2018-2023)
5.4.5 PPD Recent Developments
5.5 Eurofins Scientific
5.5.1 Eurofins Scientific Profile
5.5.2 Eurofins Scientific Main Business
5.5.3 Eurofins Scientific Preclinical CRO Services Products, Services and Solutions
5.5.4 Eurofins Scientific Preclinical CRO Services Revenue (US$ Million) & (2018-2023)
5.5.5 Eurofins Scientific Recent Developments
5.6 Taconic Biosciences
5.6.1 Taconic Biosciences Profile
5.6.2 Taconic Biosciences Main Business
5.6.3 Taconic Biosciences Preclinical CRO Services Products, Services and Solutions
5.6.4 Taconic Biosciences Preclinical CRO Services Revenue (US$ Million) & (2018-2023)
5.6.5 Taconic Biosciences Recent Developments
5.7 EVOTEC
5.7.1 EVOTEC Profile
5.7.2 EVOTEC Main Business
5.7.3 EVOTEC Preclinical CRO Services Products, Services and Solutions
5.7.4 EVOTEC Preclinical CRO Services Revenue (US$ Million) & (2018-2023)
5.7.5 EVOTEC Recent Developments
5.8 The Jackson Laboratory
5.8.1 The Jackson Laboratory Profile
5.8.2 The Jackson Laboratory Main Business
5.8.3 The Jackson Laboratory Preclinical CRO Services Products, Services and Solutions
5.8.4 The Jackson Laboratory Preclinical CRO Services Revenue (US$ Million) & (2018-2023)
5.8.5 The Jackson Laboratory Recent Developments
5.9 MI Bioresearch
5.9.1 MI Bioresearch Profile
5.9.2 MI Bioresearch Main Business
5.9.3 MI Bioresearch Preclinical CRO Services Products, Services and Solutions
5.9.4 MI Bioresearch Preclinical CRO Services Revenue (US$ Million) & (2018-2023)
5.9.5 MI Bioresearch Recent Developments
5.10 Champion Oncology
5.10.1 Champion Oncology Profile
5.10.2 Champion Oncology Main Business
5.10.3 Champion Oncology Preclinical CRO Services Products, Services and Solutions
5.10.4 Champion Oncology Preclinical CRO Services Revenue (US$ Million) & (2018-2023)
5.10.5 Champion Oncology Recent Developments
5.11 Wuxi AppTec.
5.11.1 Wuxi AppTec. Profile
5.11.2 Wuxi AppTec. Main Business
5.11.3 Wuxi AppTec. Preclinical CRO Services Products, Services and Solutions
5.11.4 Wuxi AppTec. Preclinical CRO Services Revenue (US$ Million) & (2018-2023)
5.11.5 Wuxi AppTec. Recent Developments
5.12 Xentech
5.12.1 Xentech Profile
5.12.2 Xentech Main Business
5.12.3 Xentech Preclinical CRO Services Products, Services and Solutions
5.12.4 Xentech Preclinical CRO Services Revenue (US$ Million) & (2018-2023)
5.12.5 Xentech Recent Developments
5.13 Living Tumor Laboratory
5.13.1 Living Tumor Laboratory Profile
5.13.2 Living Tumor Laboratory Main Business
5.13.3 Living Tumor Laboratory Preclinical CRO Services Products, Services and Solutions
5.13.4 Living Tumor Laboratory Preclinical CRO Services Revenue (US$ Million) & (2018-2023)
5.13.5 Living Tumor Laboratory Recent Developments
5.14 CrownBio
5.14.1 CrownBio Profile
5.14.2 CrownBio Main Business
5.14.3 CrownBio Preclinical CRO Services Products, Services and Solutions
5.14.4 CrownBio Preclinical CRO Services Revenue (US$ Million) & (2018-2023)
5.14.5 CrownBio Recent Developments
6 North America
6.1 North America Preclinical CRO Services Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Preclinical CRO Services Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Preclinical CRO Services Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Preclinical CRO Services Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Preclinical CRO Services Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Preclinical CRO Services Market Dynamics
11.1 Preclinical CRO Services Industry Trends
11.2 Preclinical CRO Services Market Drivers
11.3 Preclinical CRO Services Market Challenges
11.4 Preclinical CRO Services Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
